Rivaroxaban Viatris 20 mg

Rivaroxaban Viatris 20 mg is a pharmaceutical product used as an anticoagulant to reduce the risk of blood clots. Formulated and manufactured in multiple countries, it stems from the collaborative efforts of Mylan and Upjohn. Currently, it is owned by Viatris Inc., which aims to provide access to quality medicines globally. The product is marked with various health indications, emphasizing oral use for treating conditions related to thrombosis.